Mimedx (MDXG) Free Cash Flow Growth (3y) (2014 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | 41.96% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 24.84% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 35.29% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 25.48% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 35.42% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | 250.09% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 11.09% |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 12.01% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 9.23% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | -38.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.39% |
| Mar 31, 2026 | 31.61% |
| Dec 31, 2025 | 80.92% |
| Sep 30, 2025 | 262.83% |
| Jun 30, 2025 | 83.78% |
| Mar 31, 2025 | 35.28% |
| Dec 31, 2024 | 53.51% |
| Sep 30, 2024 | 49.84% |
| Jun 30, 2024 | 163.45% |
| Mar 31, 2024 | 38.46% |
| Dec 31, 2023 | 39.45% |
| Sep 30, 2023 | 63.45% |
| Jun 30, 2023 | 88.07% |
| Mar 31, 2023 | 29.38% |
| Dec 31, 2022 | 35.84% |
| Sep 30, 2022 | 29.74% |
| Jun 30, 2022 | -56.07% |
| Mar 31, 2022 | 13.37% |
| Dec 31, 2021 | -238.57% |
| Sep 30, 2021 | 62.49% |